In order to focus on the latest progress of endocrine therapy for breast cancer in the world and the status quo of endocrine therapy for breast cancer in China, the hot issues were discussed and the future development of the field of breast cancer was discussed. The special Committee of Breast Disease of Chengdu Hi-tech Medical Association held the breast expert salon meeting of "Fluoroyoubreast-safety" online from 19:30 to 21:30 on December 21th, 2020.

The chairman of the conference was Professor Lv Qing, director of breast Surgery department of West China Hospital of Sichuan University. The conference was presided over by Associate professor Luo Ting, Clinical Research Center of Breast Disease of West China Hospital of Sichuan University. Professor Du Zhenggui of West China Hospital of Sichuan University and Professor Wang Hao of Sichuan Cancer Hospital made special reports respectively.

Professor Lv Qing, director of breast surgery, West China Hospital, Sichuan University

Luo Ting, associate professor, Clinical Research Center of Breast Diseases, West China Hospital, Sichuan University

Professor Du Zhenggui from West China Hospital of Sichuan University shared "ADVANCE in HR+ Early Breast Cancer"

Professor Wang Hao from Sichuan Cancer Hospital shared "Endocrine Therapy Strategies for Advanced Breast Cancer"

Then the discussion was focused on four specific questions:

1. HR positive early breast cancer neoadjuvant therapy power ah exploration direction? How to set the research focus?

2. First-line endocrine therapy single drug & combined advantage population?

3. Under the condition of drug availability, how to optimize the subsequent treatment regimen after first-line CDK4/6 inhibitor resistance in hr-positive advanced breast cancer patients?

4. Which direction should Flavistry group explore in the field of HR positive advanced breast cancer?

Professor Liu Lei, Cancer Center, West China Hospital, Sichuan University

Professor Jiang Ming, head and neck oncology department, West China Hospital, Sichuan University

Professor Xie Yanyan, Department of Breast Surgery, West China Hospital, Sichuan University

Yang Xiaoqin, Professor of breast surgery, West China Hospital, Sichuan University

Yong Wei, director of the department of thyroid and breast surgery, Chengdu 7th People's Hospital

Professor Zhang Jianhui, Department of Breast Surgery, Sichuan Cancer Hospital

From the perspective of solving practical clinical problems, hot issues were discussed, which promoted the sustainable development of the subject. Through the platform, experience was shared, and common progress was made through brainstorming, so as to seek for the future development of breast cancer.